Literature DB >> 27128983

Tumor Characteristics, Genetics, Management, and the Risk of Metastasis in Uveal Melanoma.

Erin E Nichols1, Ann Richmond2,3,4, Anthony B Daniels1,3,4,5.   

Abstract

Uveal melanoma is the most common intraocular malignancy in adults. Although rates of local control for uveal melanoma exceed 95% with radiotherapy or enucleation, as many as 50% of patients develop hematogenous metastases, which manifest in the decades following initial diagnosis and are uniformly and rapidly fatal. Recent compelling evidence suggests that not all uveal melanomas are themselves equivalent with respect to metastatic potential and patient survival. This review focuses on the mounting evidence of survival disparities based on intrinsic tumor clinical and histopathologic characteristics and based on tumor genetics and gene expression profiles.

Entities:  

Keywords:  Disparities; epidemiology; genetics; metastasis; ocular tumors; ophthalmology; prognosis; risk factors; survival; uveal melanoma

Mesh:

Year:  2016        PMID: 27128983      PMCID: PMC5526754          DOI: 10.3109/08820538.2016.1154175

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN: 0882-0538            Impact factor:   1.975


  43 in total

1.  Uveal melanoma: implications of tumor doubling time.

Authors:  A D Singh
Journal:  Ophthalmology       Date:  2001-05       Impact factor: 12.079

2.  Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis.

Authors:  K Sisley; I G Rennie; M A Parsons; R Jacques; D W Hammond; S M Bell; A M Potter; R C Rees
Journal:  Genes Chromosomes Cancer       Date:  1997-05       Impact factor: 5.006

3.  Detection and time to treatment of uveal melanoma in the United Kingdom: an evaluation of 2,384 patients.

Authors:  Erika M Damato; Bertil E Damato
Journal:  Ophthalmology       Date:  2012-04-11       Impact factor: 12.079

Review 4.  Recent developments in prognostic and predictive testing in uveal melanoma.

Authors:  Matthew G Field; J William Harbour
Journal:  Curr Opin Ophthalmol       Date:  2014-05       Impact factor: 3.761

5.  Survival in patients with uveal melanoma in Europe.

Authors:  Gianni Virgili; Gemma Gatta; Laura Ciccolallo; Riccardo Capocaccia; Annibale Biggeri; Emanuele Crocetti; Jean-Michel Lutz; Eugenio Paci
Journal:  Arch Ophthalmol       Date:  2008-10

6.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

7.  A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988.

Authors:  M Diener-West; B S Hawkins; J A Markowitz; A P Schachat
Journal:  Arch Ophthalmol       Date:  1992-02

8.  Survival rates with uveal melanoma in the United States: 1973-1997.

Authors:  Arun D Singh; Allan Topham
Journal:  Ophthalmology       Date:  2003-05       Impact factor: 12.079

9.  Staging of ciliary body and choroidal melanomas based on anatomic extent.

Authors:  Emma Kujala; Bertil Damato; Sarah E Coupland; Laurence Desjardins; Nikolaos E Bechrakis; Jean-Daniel Grange; Tero Kivelä
Journal:  J Clin Oncol       Date:  2013-07-01       Impact factor: 44.544

10.  American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.

Authors:  Carol L Shields; Swathi Kaliki; Minoru Furuta; Enzo Fulco; Carolina Alarcon; Jerry A Shields
Journal:  Ophthalmology       Date:  2013-05-09       Impact factor: 12.079

View more
  15 in total

1.  Calpastatin participates in the regulation of cell migration in BAP1-deficient uveal melanoma cells.

Authors:  Han Yue; Feng-Xi Meng; Jiang Qian; Bin-Bin Xu; Gang Li; Ji-Hong Wu
Journal:  Int J Ophthalmol       Date:  2019-11-18       Impact factor: 1.779

Review 2.  Consensus statement for metastatic surveillance of uveal melanoma in Scotland.

Authors:  Vikas Chadha; Paul Cauchi; Wilma Kincaid; Ashita Waterston; Stefano Schipani; Sachin Salvi; Oliver Cram; Diana Ritchie
Journal:  Eye (Lond)       Date:  2022-08-09       Impact factor: 4.456

3.  A Predictive Web-Based Nomogram for Elderly Patients Newly Diagnosed as Uveal Melanoma: A Population-Based Study.

Authors:  Meng Lv; Xinhua Yan; Yuanxing Tu
Journal:  Front Med (Lausanne)       Date:  2022-06-23

4.  Primary Orbital Melanoma: Presentation, Treatment, and Long-term Outcomes for 13 Patients.

Authors:  Anna M Rose; Philip J Luthert; Channa N Jayasena; David H Verity; Geoffrey E Rose
Journal:  Front Oncol       Date:  2017-12-18       Impact factor: 6.244

5.  Characterization of luteinizing hormone-releasing hormone receptor type I (LH-RH-I) as a potential molecular target in OCM-1 and OCM-3 human uveal melanoma cell lines.

Authors:  Eva Sipos; Nikoletta Dobos; David Rozsa; Klara Fodor; Gabor Olah; Zsuzsanna Szabo; Lorant Szekvolgyi; Andrew V Schally; Gabor Halmos
Journal:  Onco Targets Ther       Date:  2018-02-22       Impact factor: 4.147

6.  Somatostatin Receptors as Molecular Targets in Human Uveal Melanoma.

Authors:  Kristof Harda; Zsuzsanna Szabo; Erzsebet Szabo; Gabor Olah; Klara Fodor; Csaba Szasz; Gabor Mehes; Andrew V Schally; Gabor Halmos
Journal:  Molecules       Date:  2018-06-26       Impact factor: 4.411

7.  Adjuvant Ipilimumab in High-Risk Uveal Melanoma.

Authors:  Eric Fountain; Roland L Bassett; Suzanne Cain; Liberty Posada; Dan S Gombos; Patrick Hwu; Agop Bedikian; Sapna P Patel
Journal:  Cancers (Basel)       Date:  2019-01-29       Impact factor: 6.639

8.  Increased Non-Homologous End Joining Makes DNA-PK a Promising Target for Therapeutic Intervention in Uveal Melanoma.

Authors:  Rachel E Doherty; Helen E Bryant; Manoj K Valluru; Ian G Rennie; Karen Sisley
Journal:  Cancers (Basel)       Date:  2019-08-30       Impact factor: 6.639

9.  An amelanotic choroidal melanoma arising in a young man with tattoo-associated sarcoidosis.

Authors:  Sean T Berkowitz; Anderson L Brock; David A Reichstein
Journal:  Am J Ophthalmol Case Rep       Date:  2020-03-07

10.  MiR-155 Promotes Uveal Melanoma Cell Proliferation and Invasion by Regulating NDFIP1 Expression.

Authors:  Jing Peng; Honglei Liu; Cuihong Liu
Journal:  Technol Cancer Res Treat       Date:  2017-11-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.